Glycemic Control in Type 2 Diabetes Mellitus Patients

Similar documents
HbA1 C in Patients with Gestational Diabetes Mellitus

International Journal of Health Sciences and Research ISSN:

HBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT

Journal of Medical Science & Technology

Iron Status in Chronic Renal Failure with Anemia

Association of Thyroid Hormone Levels Among Type 2 Diabetic Patients Attending a Tertiary Care Hospital

Serum Calcium, Inorganic Phosphate and Serum Alkaline Phosphatase levels in Type 2 Diabetes Mellitus

Diabetes Mellitus Type 2 Evidence-Based Drivers

Research Article ISSN Vol 2/Issue 3/Jul-Sept 2012 *G. SOMASUNDARAM, K. MANIMEKALAI, KARTIK J. SALWE AND J. PANDIAMUNIAN.

A study of micro vascular complications and associated risk factors in newly diagnosed patients of type 2 diabetes mellitus

Diabetes in the Elderly 1, 2, 3

Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre

Monitoring Diabetes Mellitus with HBA 1 C: The Abakaliki, Nigeria Experience

A COMPARATIVE EVALUATION OF HBA1C MEASUREMENT IN DIFFERENT ANTICOAGULANT VIALS AND ITS STABILITY ON STORAGE

A correlative study of HbA 1 C and lipid profile parameters among type 2 diabetic population in a rural hospital in puducherry.

HbA1c, a gold standard parameter, is really a gold standard in chronic alcoholic liver disease?

JMSCR Vol 06 Issue 10 Page October 2018

Correlation between glycosylated hemoglobin level and lipid profile in patients with diabetes mellitus

Chapter 37: Exercise Prescription in Patients with Diabetes

DIABETO SUMMIT. Diabeto Summit

Study of significance of glycosylated hemoglobin in diabetic patient

Alarming Frequency of Gestational Diabetes Mellitus (GDM) Attending a Tertiary Care Hospital in Bangladesh

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test

A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy

EFFECT OF BIOCHEMICAL PARAMETERS SHOWING ATHEROGENICITY IN TYPE 2 DIABETIC NEPHROPATHY

HBA1C: PREDICTOR OF DYSLIPIDEMIA AND ATHEROGENICITY IN DIABETES MELLITUS

The Metabolic Syndrome: Is It A Valid Concept? YES

What s the Goal? Individualizing Glycemic Targets. Matthew Freeby M.D. December 3 rd, 2016

Key words: Diabetes, Anaemia, Glycemic Control, HbA1c, Micro and Macro Vascular Complications.

A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c

Modulating the Incretin System: A New Therapeutic Strategy for Type 2 Diabetes

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Relationship Between Serum Ferritin Level and Hba 1c in Bangladeshi Type 2 Diabetic Patients

International Journal of Pure and Applied Sciences and Technology

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

About the Project Education Play Community Games Publications News Help Home

Usefulness of Ambulatory Glucose Profile (AGP) in Diabetes Care

Diabetic Dyslipidemia

Serum uric acid levels and its association with type 2 diabetes mellitus. Received: / Revised Accepted: / Published:

Smoking and Ischemic Stroke

Analysis of drug used for the treatment of complications of diabetes in a teaching hospital

CLINICAL PROFILE OF TYPE 2 DIABETIC PATIENTS IN A TERTIARY CARE HOSPITAL IN COASTAL KARNATAKA

Sanofi Announces Results of ORIGIN, the World s Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes

[Frida Svendsen and Jennifer Southern] University of Oxford

A Study on the Presence of Islets Cell Autoantibodies in Non- Insulin Requiring Young Diabetic Patients

Dr. T. Bhuvaneswari * Original Research Article. Abstract

associated with serious complications, but reduce occurrences with preventive measures

Hemoglobin A1c: Comparison of Pointe Scientific s 2-Part Direct Hemoglobin A1c with the Bio-Rad Variant II and the Tosoh G8

ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

A Comparative Study of Thyroid Function in Patients of Type 2 Diabetes Mellitus without Nephropathy and Type 2 Diabetes Mellitus With Nephropathy.

Effects of Glibenclamide and Glimepiride Compared in Type II DM Patients in Accordance with Lipid Parameters, ESF and Glycated Haemoglobin

Asian Journal of Medical and Biological Research ISSN (Print) (Online)

The hallmark of type 2 diabetes mellitus (T2DM) is progressive

Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population Abstract

Stress Response to Surgery Under General Anesthesia in Type 2 Diabetic Patient

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

These results are supplied for informational purposes only.

Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy

Keywords: glycosylated haemoglobin, plasma glucose, correlation.

Isam Hamo Mahmood & Wail Moneer Mohammed Sadiq

These results are supplied for informational purposes only.

COMPARISON OF HIGHLY SENSITIVE CRP AND SERUM CREATININE AS AN EARLY MARKER OF RENAL IMPAIRMENT

Detecting Type 2 diabetes and impaired glucose regulation using glycated hemoglobin in different populations

Initial Mono Versus Combination Therapy for Type 2 Diabetes

The Many Faces of T2DM in Long-term Care Facilities

IJBCP International Journal of Basic & Clinical Pharmacology

Correlation Study of Insulin Resistance and Essential Hypertension among Bangladeshi Male Volunteers

Other Ways to Achieve Metabolic Control

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

Association of Plasma Lipid profile and HbA1c among Saudi Patients with Coronary Heart Diseases, at King Abdulaziz Medical City, Riyadh

Association of Glycosylated Haemoglobin Level with the Severity of Coronary Artery Disease in NSTEMI Diabetic Patients

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

Evaluation of serum ferritin in in type II diabetes mellitus: a hospital based observational study from Dibrugarh, Assam, India

ATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease

Biochemistry. ENDOCRINE Block Practical Sessions. Editing file M E D I C I N E

SCIENTIFIC STUDY REPORT

SUMMARY AND CONCLUSION

DICE Study Backgrounder

Supplementary Data. Formula S1. Calculation of IG fluctuation from continuous glucose monitoring profiles Z T 1 T

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Approach to the Young child & Parent with Child with DM Best Structure for Continued Care

Internationally Indexed Journal

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

Presenter Disclosure

The effect of educational intervention on knowledge, attitude and glycemic control in patients with type 2 diabetes mellitus

PREVALENCE STUDY ABOUT HIGH BLOOD SUGAR AMONG THE PEOPLE ABOVE 35YEARS OLD BASED ON THEIR GROUP OF AGES

Diabetic Nephropathy

Effectiveness of Training Session in Improvement of Insulin Administration Technique in Diabetic Patients

Diabetes Management and Considerations for the Indian Culture

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)

Rat Hemoglobin A1c (HbA1c) Kit Instructions

Transcription:

Chattagram Maa-O-Shishu Hospital Medical College Journal DOI: 10.11566/cmosh.2013.1201.4 Original Article Glycemic Control in Type 2 Diabetes Mellitus Patients Siddiqui SRA 1 Rahman MZ 2 * Alam ASMT 1 Hoque M 1 1 Department of Biochemistry, Chittagong Medical College, Chittagong, Bangladesh 2 Department of Pathology, Chittagong Medical College, Chittagong, Bangladesh Abstract Background: Some population-based studies conducted in Bangladesh at different time points have revealed an increasing trend of diabetes prevalence ranging from 1.5% to 3.8% in the rural communities. The diagnosis of diabetes mellitus must be made with care since it has far reaching medical and social consequences. A number of biochemical tests are used in association with clinical assessment both for the initial diagnosis of this condition and the long-term monitoring of patients. Glycated hemoglobin provides an accurate and objective measure of glycemic control over a period of weeks to months. This study was designed to find the status of glycemic control in diabetic patients. Materials and Methods: A total number of 60 diabetic patients of various duration from > 20 years were included in the study group and 40 non-diabetic individuals in the control group. Biochemical parameters fasting plasma glucose (FPG), 2 hours post-prandial plasma glucose (PPPG) and HbA 1 c were studied. All the data were analyzed by using SPSS (Statistical Product and Service Solutions) version 12.0 for Windows software with a 95% confidence limit. Results: In the study group with mean FPG 8.28 mmol/l and mean 2 hours PPPG 12.09 mmol/l and mean HbA 1 c was 7.41%. All the parameters showed significant difference between study group and control group. FPG, PPPG and HbA 1 c were all increased in diabetic patients when compared to that of control group. Conclusion: Glycemic control is impaired in diabetic patients. Longer duration of diabetes mellitus shows less glycemic control. Key words: Diabetes; glycemic control; HbA 1 c, duration. *Correspondence to: Dr Md. Zillur Rahman Associate Professor, Department of Pathology, Chittagong Medical College, Chittagong, Bangladesh E-mail: drzillur@gmail.com Mobile: +88-01819-315116 How to cite this article: Siddiqui SRA, Rahman MZ, Alam ASMT Hoque M, Glycemic control in type 2 diabetes mellitus patients. Chatt Maa Shi Hosp Med Coll J 2013; 12(1): 4. Introduction Recent epidemiological reports indicated an increased prevalence of Type-2 diabetes in Turkey (7.2%), India (8.2%), Pakistan (11.1%), and Hawaii (20.4%). It is estimated that the developing countries will bear the brunt of diabetes epidemics in the 21st century. Some population-based studies conducted in Bangladesh at different time points have revealed an increasing trend of diabetes prevalence ranging from 1.5% to 3.8% in the rural communities. Bangladeshis are more susceptible to develop diabetes, hyperinsulinemia, and coronary heart disease (CHD) compared with other South Asian migrants (Indians, Pakistani) settled in the UK. The risk factors related to these disorders were more prevalent in the population of Bangladesh than in the native population. Also, in Bangladesh these diseases are emerging as major health problems, and the government has given them high research priority. It may be mentioned that a vast majority (77.6%) of the national population lives 4 www.cmoshmcj.org

Glycemic control in type 2 diabetes mellitus patients in the rural areas. Only two studies were conducted in rural areas, but these studies contained small samples. 1 The diagnosis of diabetes mellitus must be made with care since it has far reaching medical and social consequences. A number of biochemical tests are used in association with clinical assessment both for the initial diagnosis of this condition and the long-term monitoring of patients. 2 Glycated haemoglobin provides an accurate and objective measure of glycaemic control over a period of weeks to months and these haemoglobin moieties are increased in diabetes by the slow non-enzymatic covalent attachment of glucose and other sugars. A rise of 1% in glycated-hb corresponds to an approximate increase of 2 mmol/l in average blood glucose. 3 Each 1% decrease in A 1C translates into a 35% 40% decrease in the frequency of microvascular complications. 4 Bangladesh is one of the poorest countries in the world and has the lowest health care spending per capita. The prevalence of diabetes in Bangladesh is estimated to be 5.2% among the adult population. It is estimated that almost 3 million people in Bangladesh have diabetes. The majority has type-2 diabetes. Because the current state of diabetes care in the country is poor, the benefits of greater investment in diabetes care were particularly striking. In an improved scenario, assuming free access to the current level of diabetes care for the estimated 3 million people who currently have type-2 diabetes in Bangladesh, the number would double to 5.8 million and the production value almost triple. Achieving these gains for all people with diabetes would require 7 8 times the current investment in diabetes care in Bangladesh. 1 This study was designed to find the status of glycemic control in diabetic patients. Materials and Methods A cross sectional comparative study was carried out in the Department of Biochemistry of Chittagong Medical College with joint collaboration of Chittagong Diabetic Hospital from November 2004 to May 2005. Previously diagnosed 60 diabetic patients treated with either hypoglycaemic drugs or insulin within 30 70 years of age were included in the study group. Forty healthy adult volunteers of different age with no evidence of diabetes mellitus or impaired glucose tolerance were included as control subjects. After overnight (minimum 8 hours) fasting, 5 ml of whole blood was collected both from diabetic patients and healthy controls with all aseptic precautions, using a 5 cc disposable syringe at fasting and 2 hours after breakfast with or without oral hypoglycemic drug or insulin as they were prescribed earlier. The plasma was separated and kept to measure fasting plasma glucose (FPG). The 2 hours postprandial samples were used 2 measure 2 hours postprandial plasma glucose (PPPG) and HbA 1C. FPG and 2 hours PPPG were analyzed by glucose oxidase method, HbA1c was analyzed by Nycocard in vitro test. Clear plasma obtained after centrifugation of both fasting and 2 hours postprandial blood samples were transferred to eppendorf tubes and preserved at 35 o C in a refrigerator till analysis was completed. Detailed history and clinical findings of the subjects were recorded. All the analysis was done using the SPSS (Statistical Package for Social Science) 12-version software package for windows. Parameters were expressed as mean±sd (standard deviation) as appropriate. Pearson correlation coefficient was analyzed to show the correlation between different parameters in the study group. The P value of < 0.05 was considered as statistically significant. Results and Observations Among the 60 cases the mean age is 54.52 years ranging from 35 74 years. Forty individuals of control group have mean age of 51.8 years ranging from 34 77 years. Majority of the study individuals were within 51 60 years of age. Male patients are more in number in relation to female patients. Control individuals also show male predominance. Among the study group of 60 individuals 32 male and 28 female diabetic patients were included and among control group 23 male and 17 female individuals were included. In this study, a total of 55 males and 45 females were included (Table 1). Mean FPG of 60 individuals of study group is 8.28 ± 2.72 mmol/l ranging from 4.6 to 17.3 mmol/l, whereas mean FPG of 40 control individuals is 4.75 ± 0.68 ranging from 3.9 Table 1: Age distribution Age distribution Sex distribution Group N Mean±SD T P Male (%) Female (%) Study 60 54.52 ± 8.949 1.33 0.185 32 (53.3) 28 (46.7) Control 40 51.80 ± 11.34 23 (57.5) 17 (42.5) 5

Siddiqui SRA et al to 6.3 mmol/l. Unpaired T test shows highly significant difference (P< 0.001). Mean 2 hours PPPG with drug or insulin of 60 diabetic individuals of study group is 12.09 ± 3.92 mmol/l ranging from 5.4 to 24.5 mmol/l. Whereas the mean 2 hours PPPG of 40 control individuals is 6.56 ± 0.58 ranging from 5.3 to 7.7 mmol/l. Unpaired T test shows significant difference between case and control (P< 0.001). Again, the mean glycated hemoglobin level of study group was found 7.41 ± 1.51% ranging from 4.6% 11.9%, whereas the mean HbA 1 c in control group is 5.63% ± 0.66% ranging from 4% 6%. Unpaired T test was done and found highly significant difference between study and control groups for glycated hemoglobin level (Table 2). Pearson correlation test shows that there is significant correlation among FPG and 2 hours PPPG (P< 0.001), FPG and HbA1c (P< 0.01) and 2 hours PPPG and HbA1c (P< 0.001) (Table 3). Mean duration of diabetes in study group is 11.13 years where minimum duration of diabetes is 1 year and maximum duration is 30 years. According to the duration of diabetes mellitus, the study group was divided into five sub-group as (1) up to 5 years, (2) 6 10 years, (3) 11 15 years, (4) 16 20 years and (5) > 20 years. The frequency distribution was 13 in group-1, 21 in group-2, 15 in group- 3, 6 in group-4 and 5 in group-5. suffering from diabetes mellitus were in the group 2 ranging 6 to 10 years. All the other variables i.e. FPG, PPPG, HbA1c were correlated with duration groups to see whether there is any increase or decrease of these variables along the increasing duration of diabetes. It was seen that FPG is almost similar in duration groups 1 and 2. FPG increases in duration groups 3, 4 and 5. But in group 4, FPG is relatively low. Similar result was seen in 2 hours PPPG also. This result indicates that FPG and 2 hours PPPG gradually increase along with the duration of diabetes. Glycated hemoglobin was also seen to be increasing gradually along with the increased duration of diabetes. But group 4 shows a relative reduction of HbA 1 c. (Table 4) It was seen that there is a gradual rise in FPG, 2 hours PPPG and HbA1c levels in relation to duration of diabetes. Table 2: FPG, 2 hour s PPPG and HbA1c Variables Group N Mean±SD T P Sig. FBG Study 60 8.28 ± 2.72 8.046 < 0.001 Sig. Control 40 4.75 ± 0.68 PPBG Study 60 12.09 ±3.92 8.827 < 0.001 Sig. Control 40 6.56 ± 0.58 HbA 1 c Study 60 7.41 ± 1.51 7.004 < 0.001 Sig. Control 40 5.63 ± 0.66 Table 3: Pearson Correlations among FPG, PPPG and HbA1c Correlation between Variable Mean±SD r P value FPG & PPPG FPG 8.28 ± 2.72 0.696 < 0.001 PPPG 12.09 ± 3.92 FPG & HbA1c FPG 8.28 ± 2.72 0.391 < 0.01 HbA1c 7.41 ± 1.51 PPPG & HbA1c PPPG 12.09 ± 3.92 0.432 < 0.001 HbA1c 7.41 ± 1.51 Table 4: Mean FPG and PPPG in different duration groups Duration (duration groups) Duration (years) N (%) Mean FPG Mean PPPG Mean HbA1c (%) 1 Upto 5 14 (23.3) 7.9 11.3 7.13 2 6 10 20 (33.3) 7.7 11.8 7.31 3 11 15 15 (25.0) 9.2 13.6 8.11 4 16 20 06 (10.0) 8.8 10.2 6.9 5 > 20 05 (08.3) 9.5 13.2 7.1 6

Glycemic control in type 2 diabetes mellitus patients But Pearson correlation gives no significant result in relation to duration of diabetes. (Table 5) Table 5: Pearson Correlation of FPG with duration groups Variable Mean±SD r P value Duration (Duration group) 54.52 ± 8.95 (2.78 ± 0.94) FPG 8.28 ± 2.72 0.188 0.150 PPPG 12.09 ± 3.92 0.101 0.444 Glycated haemoglobin 7.41 ± 1.51 0.035 0.790 In 60 individuals of diabetic cases the HbA1c% level was again graded in to good (intensive), average (acceptable) and poor control according to their glycemic control as < 6, 6 7 and > 7% respectively. 5 (On analysis, the frequency distribution was found that 15% (9 cases) were in good, 25% (36 cases) in average and 60% (36 cases) in poor glycemic control. (Table 6) Table 6: Groups on glycaemic control of HbA1c% Glycaemic control (%) Frequency Percent (%) Good (< 6) 9 15 Average (6-7) 15 25 Poor (> 7) 36 60 Total 60 100 Discussion The present study investigated the status glycemic control among 60 type-2 diabetic patients of various durations from < 5 to > 20 years in study group and 40 non-diabetic individuals as control group as well as the effect of duration of diabetes on FPG, 2 hours PPPG and HbA1c. Correlations of FPG, 2 hours PPPG and HbA1c were also seen. Mean duration of diabetes in study group was 11.1 years. Majority of them were within 6 10 years duration, followed by 11 15 years duration group. This observation indicated that diabetic patients have raised FPG. 2 hours PPPG and HbA1c indicated poor glycaemic control. In this study, FPG of study group (mean 8.28 mmol/l) shows highly significant difference (P value < 0.001) with FPG of control group (mean 4.75 mmol/l). And 2 hours PPPG with or without drug or insulin of study group (mean 12.09 mmol/l) also shows significant difference (P< 0.001) with PPPG of control group (mean 6.56 mmol/l). Similar results were obtained in a study carried out on insulin resistance and insulin secretory dysfunction in obese Bangladeshi type 2 diabetic subjects. 6 Glycated hemoglobin (HbA 1 c%) level of study group (mean 7.41%) showed highly significant difference (P< 0.001) with that of control group (mean 5.63%). This observation is consistent with a study on HbA1c in diagnosis of diabetes mellitus without ketonuria in young adult. 7 When FPG, PPPG and HbA1c were analyzed with Pearson s correlation, it was found that there are significant correlation among FPG, PPPG and HbA1c. This observation is also consistent with a previous study that showed a positive correlation between fasting blood glucose and HbA1c level. 7 FPG, PPPG and HbA1c did not show any significant correlation with duration of diabetes indicating that glycemia is not proportional to duration and may be controlled if necessary measures are taken in time. This result does not conform to the observation of Mobede and Masoomi. 8 They worked on 312 patients and found a positive correlation of HbA1c with longer duration of diabetes. This discrepancy was possibly due to the smaller sample size of this study. Again HbA1c% level was sub-classified to good (< 6%), average (6% 7%) and poor (> 7%) according to their glycemic control. 5 It was found that the majority of the diabetic patients in study group are in poor (HbA1c > 7%) glycemic control. It indicates unawareness and carless attitude of diabetic patients in our country. Conclusion Bangladeshi type 2 diabetes patients are unaware of their glycemic control. But this raised glycemic status does not correlate with duration of diabetes. All the parameters like FPG, 2 hours PPPG and HbA1c correlate and thus HbA1c can be considered as a diagnostic parameter. The limitation of this study is a relatively smaller sample size and spot analysis of biochemical parameters. A study with a larger sample size for a long duration with multiple timed sampling of biochemical parameters is suggested. 7

Siddiqui SRA et al REFERENCES 1. Sayeed MA, Mahtab H, Khanam PA, Latif Z A, Ali SMK, Banu A, et al. Diabetes and impaired fasting glycemia in a rural population of Bangladesh. Diabetes Care. 2003;26:1034 39. 2. Gaw A, Cowan RA, O Reilly DSJ, Stewart MJ, Shepherd J, editors. Clinical biochemistry. New York: Churchill Livingstone Inc., 1995. pp. 58 59. 3. Hauslett C, Chilvers ER, Hunter JAA, Boon NA. Davidson s principles and practice of medicine. 18th ed. 1999. pp. 489 90. 4. Abbate SL. Expanded ABCs of Diabetes. Clin Diabetes. 2003;21(3):128 133. 5. Defranzo RA. Diabetic nephropathy. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 3rd ed. PA: Lippincott Williams and Wilkins; 2002. pp. 1403 18. 6. Tobe SW, McFarlane PA, Naimark DM. Microalbuminuria in diabetes mellitus. CMAJ. 2002;167(5):499. 7. Nazimuddin K, Ahmed, T, Hoque MS, Musa AKM, Sarker RSC. HbA1c in diagnosis of diabetes mellitus without ketonuria in young adult. JBCPS. 2004;22(3):100 3. 8. Mobede O, Masoomi M. Microalbuminuria and associated factors in Bahraini patients with type-2 diabetes mellitus. Annals of Saudi Medicine. 2000;20:157 60. 8